Enersys outlines Q3 FY2027 EPS of $3.05 to $3.15 as it plans $320M Ultralife deal with $15M to $20M synergies

M-tron projects 2028 growth in the high teens as missile replenishment demand drives capacity expansion

Fractyl outlines plan to cut quarterly operating cash spending to ~$8M by end of Q2 2027 as Revita heads toward de novo submission

CV Sciences outlines multiple +PlusHLTH launches over next 12 to 24 months as Q3 gross margin reaches 50%

Legence forecasts $5.3B-$5.6B 2027 revenue and $690M-$730M EBITDA as it authorizes share repurchases